The benign tumor that keeps the King of England from sleeping at night and embitters

Buckingham Palace has announced that King Charles III of England will undergo surgery next week for benign prostatic hyperplasia. The British royal house, which is not inclined to give many details about the health of its members, has chosen to announce it to give visibility to these disorders and raise awareness among men about the need to undergo periodic check-ups at the urologist. Prostate problems affect one in four men over 50 years of age and, according to data from the Spanish Association of Urology (AEU), from the age of 70 onwards, 90% of men suffer some discomfort related to this organ. Apart from prostate cancer, there are a good number of benign prostate ailments – hyperplasia, prostatitis, etc. – whose fundamental problem is that they cause compression of the urethra that hinders the proper flow of urine. Benign prostatic hyperplasia is the most common benign tumor in men. With a histological prevalence that goes from 8% at the age of 40 to 90% after the age of 80, it causes the death of 30 out of every 100,000 men in developed countries and is one of the diseases that causes the greatest health expenditure. The common symptoms of an enlarged prostate are increased daily urination, increasing difficulty in initiating urination, a thinner and less powerful stream of urine, and the sensation of incomplete emptying of urine. Approximately 75% of men aged 80 will suffer some clinical manifestation caused by prostate hypertrophy. Related News standard No Impotence drugs can increase the risk of death IR A study warns of their use when combined with common medications for cardiovascular diseases 3 complications of benign prostatic hyperplasia Many men assume that the damage caused by this pathology are associated with age. The most immediate consequence is a significant alteration in the quality of life and nighttime sleep, due to the continuous or intermittent presence of voiding symptoms, filling (urgency, increased voiding frequency, urine leakage) or emptying (loose and choppy stream, post-micturition dribbling), even with concomitant erectile dysfunction. However, urologists warn that if benign prostatic hyperplasia is not properly treated, patients may suffer complications that go beyond the discomfort: 1. Urine retention: when urethral obstruction worsens, bladder contractions are insufficient. and do not allow a complete emptying of it. 2. Infections and stone formations: Residual urine in the bladder can become infected or cause painful stones to form in the bladder. 3. Kidney damage: produced as a result of increased pressure in the kidneys from an overworked bladder. Patients may benefit from medical treatment when urinary tract obstruction is mild or moderate. Nowadays there are numerous solutions to treat HTN, so it is always advisable to consult a urologist. Medical treatment can be carried out with various pharmaceutical products: products obtained from plants (phytotherapy), products that act on the innervation of the prostate gland (Alpha blockers) and drugs that block the enzymatic mechanisms that control the growth of the prostate gland ( 5-Alpha-reductase inhibitors). Depending on the degree of severity, experts will advise pharmacological or surgical treatments.